Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter October 5, 2020

Evaluation of antidiabetic effect of Cistus salviifolius L. (Cistaceae) in streptozotocin-nicotinamide induced diabetic mice

  • Karima Sayah EMAIL logo , Hanae Naceiri Mrabti , Badia Belarj , Faouzi Kichou , Yahia Cherrah and My El Abbes Faouzi

Abstract

Objectives

Cistus salviifoluis L. is a shrub from Cistaceae family used in many traditional medicines for the treatment of various diseases including diabetes mellitus. The aim of this study was to evaluate the in vivo antidiabetic potential of the aerial parts aqueous extract of Cistus salviifolius L. (CSA).

Methods

Experimental diabetes was induced in adult male mice by intra-peritoneal injection of Streptozotocin-nicotinamide (STZ-NC). CSA at a dose of 500 mg/kg was administered daily to the diabetic mice for four weeks. The effect of the extract on hyperglycemia, body weight, serum total cholesterol, triglycerides, hepatic and renal functional markers were determined. Histopathological examination of the mice pancreas was also performed. The diabetic animals treated with CSA were compared with animals treated by the standard drug metformin.

Results

Treatment with CSA showed a significant reduction in blood glucose, total triglycerides and creatinine levels and prevented the reduction of body weight caused by diabetes. Furthermore, histopathological analysis of the mice pancreas showed that the group treated with CSA reduced damage induced by STZ-NC on islets of Langerhans cells when compared to the diabetic control.

Conclusions

The results suggest that the aqueous extract of Moroccan C. salviifolius L. possesses beneficial effect on treatment of diabetes.


Corresponding author: Karima Sayah, Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Biopharmaceutical and Toxicological Analysis Research Team, Mohammed V University in Rabat, Rabat Institute, Rabat, Morocco, Phone: +212 637020220, E-mail:

Acknowledgments

The authors are thankful to Pr. Soufiane Derraji (Faculty of Medicine and Pharmacy of Rabat, Morocco) and Dr. Zohra Ouzzif (Biochemistry Department, Military Hospital Mohammed V, Rabat, Morocco) for their support in biochemical analysis, and to Dr. Ilias Marmouzi (Faculty of Medicine and Pharmacy of Rabat, Morocco) for his assistance in the laboratory. We are also thankful to Pr. Halim Khamar (Botanical Department of the Scientific Institute of Rabat, Morocco) for plant authentication.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The recommendations described in the Guide for the Care and Use of Laboratory Animals, prepared by the National Academy of Sciences and published by the National Institutes of Health were followed in the experimental procedure. Ethics approval was obtained from the University Mohammed V in Rabat, Morocco.

References

1. Alberti, KGMM, Zimmet, PF. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Diabet Med 1998 Jul;15:539–53. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-SSearch in Google Scholar

2. Cho, NH, Shaw, JE, Karuranga, S, Huang, Y, da Rocha Fernandes, JD, Ohlrogge, AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271–81. https://doi.org/10.1016/j.diabres.2018.02.023.10.1016/j.diabres.2018.02.023Search in Google Scholar

3. Scheen, AJ. Pathophysiology of type 2 diabetes. Acta Clin Belg 2003; 58: 335–41. Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553. https://doi.org/10.1179/acb.2003.58.6.001.10.1179/acb.2003.58.6.001Search in Google Scholar

4. Yang, W, Lu, J, Weng, J, Jia, W, Ji, L, Xiao, J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090–101. https://doi.org/10.1056/nejmoa0908292.10.1056/NEJMoa0908292Search in Google Scholar

5. Thanh, HN, Huyen, NT, Van Khanh, N, Thu, DK, Tung, BT. Phytochemicals and antidiabetic activity of the aqueous extract of the Punica granatum fruit in streptozotocin-induced diabetic mice. J Basic Clin Physiol Pharmacol 2019;30. doi:https://doi.org/10.1515/jbcpp-2019-0061.10.1515/jbcpp-2019-0061Search in Google Scholar

6. Akuodor, GC, Eban, LK, Ajoku, GA, Nwobodo, NN, Akpan, JL, Ezeokpo, BC, et al. Antidiabetic and antihyperlipidemic potential of ethanol extract of Salacia lehmbachii stem bark in alloxan-induced diabetic rats. J Basic Clin Physiol Pharmacol 2018; 30: 239–44. https://doi.org/10.1515/jbcpp-2018-0059.10.1515/jbcpp-2018-0059Search in Google Scholar

7. Idm’hand, E, Msanda, F, Cherifi, K. Ethnopharmacological review of medicinal plants used to manage diabetes in Morocco. Clin Phytosci 2020; 6: 1–32. doi:https://doi.org/10.1186/s40816-020-00166-z.10.1186/s40816-020-00166-zSearch in Google Scholar

8. Attaguile, G, Perticone, G, Mania, G, Savoca, F, Pennisi, G, Salomone, S. Cistus incanus and Cistus monspeliensis inhibit the contractile response in isolated rat smooth muscle. J Ethnopharmacol 2004; 92: 245–50. https://doi.org/10.1016/j.jep.2004.02.020.10.1016/j.jep.2004.02.020Search in Google Scholar

9. Zidane, H, Aouniti, F, Tahani, A, Fauconnier, ML, Elbachiri, A. Screening of mineral elements in Cistus ladanifer and Cistus libanotis essential oils and their leaves. Orient J Chem 2014; 29: 1319–24. http://dx.doi.org/10.13005/ojc/290407.10.13005/ojc/290407Search in Google Scholar

10. Bnouham, M, Mekhfi, H, Legssyer, A, Ziyyat, A. Ethnopharmacology Forum Medicinal plants used in the treatment of diabetes in Morocco. Int J Diabetes Metabol 2002; 10: 33–50.Search in Google Scholar

11. Polat, R, Satıl, F. An ethnobotanical survey of medicinal plants in Edremit Gulf (Balıkesir–Turkey). J Ethnopharmacol 2012; 139: 626–41. https://doi.org/10.1016/j.jep.2011.12.004.10.1016/j.jep.2011.12.004Search in Google Scholar

12. Papaefthimiou, D, Papanikolaou, A, Falara, V, Givanoudi, S, Kostas, S, Kanellis, AK. Genus Cistus: a model for exploring labdane-type diterpenes’ biosynthesis and a natural source of high value products with biological, aromatic, and pharmacological properties. Front Chem 2014; 2: 35. https://doi.org/10.3389/fchem.2014.00035.10.3389/fchem.2014.00035Search in Google Scholar PubMed PubMed Central

13. Sayah, K, Marmouzi, I, Naceiri Mrabti, H, Cherrah, Y, Faouzi, MEA. Antioxidant activity and inhibitory potential of Cistus salviifolius (L.) and Cistus monspeliensis (L.) aerial parts extracts against key enzymes linked to hyperglycemia. BioMed Res Int 2017a;2017:1–7. https://doi.org/10.1155/2017/2789482.10.1155/2017/2789482Search in Google Scholar PubMed PubMed Central

14. Sayah, K, Chemlal, L, Marmouzi, I, El Jemli, M, Cherrah, Y, Faouzi, MEA. In vivo anti-inflammatory and analgesic activities of Cistus salviifolius (L.) and Cistus monspeliensis (L.) aqueous extracts. South Afr J Bot 017b;113:160–3. https://doi.org/10.1016/j.sajb.2017.08.015.10.1016/j.sajb.2017.08.015Search in Google Scholar

15. Badole, SL, Bodhankar, SL. Antidiabetic activity of cycloart-23-ene-3β, 25-diol (B2) isolaMted from Pongamia pinnata (L. Pierre) in streptozotocin–nicotinamide induced diabetic mice. Eur J Pharmacol 2010; 632: 103–9. https://doi.org/10.1016/j.ejphar.2010.01.019.10.1016/j.ejphar.2010.01.019Search in Google Scholar PubMed

16. Palsamy, P, Subramanian, S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother 2008; 62: 598–605. https://doi.org/10.1016/j.biopha.2008.06.037.10.1016/j.biopha.2008.06.037Search in Google Scholar PubMed

17. Matsuyama-Yokono, A, Tahara, A, Nakano, R, Someya, Y, Hayakawa, M, Shibasaki, M. Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA 1c level, glucose intolerance, and lipid parameter level in streptozotocin–nicotinamide-induced diabetic mice. Naunyn-Schmiedeberg’s Arch Pharmacol 2009; 379: 191. https://doi.org/10.1007/s00210-008-0348-x.10.1007/s00210-008-0348-xSearch in Google Scholar PubMed

18. Rena, G, Hardie, DG, Pearson, ER. The mechanisms of action of metformin. Diabetologia 2017; 60: 1577–85. https://doi.org/10.1007/s00125-017-4342-z.10.1007/s00125-017-4342-zSearch in Google Scholar PubMed PubMed Central

19. Flory, J, Lipska, K. Metformin in 2019. Jama 2019; 321: 1926–7. https://doi.org/10.1001/jama.2019.3805.10.1001/jama.2019.3805Search in Google Scholar PubMed PubMed Central

20. Swanston-Flatt, SK, Day, C, Bailey, CJ, Flatt, PR. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia 1990; 33: 462–4. https://doi.org/10.1007/bf00405106.10.1007/BF00405106Search in Google Scholar PubMed

21. Krauss, RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004; 27: 1496–504. https://doi.org/10.2337/diacare.27.6.1496.10.2337/diacare.27.6.1496Search in Google Scholar PubMed

22. Pang, J, Chan, DC, Watts, GF. Origin and therapy for hypertriglyceridaemia in type 2 diabetes. World J Diabetes 2014; 5: 165. https://doi.org/10.4239/wjd.v5.i2.165.10.4239/wjd.v5.i2.165Search in Google Scholar

23. Ahangarpour, A, Oroojan, AA, Khorsandi, L, Shabani, R, Mojaddami, S. Preventive effects of betulinic acid on streptozotocin nicotinamide induced diabetic nephropathy in male mouse. J Nephropathol 2016; 5: 128. https://doi.org/10.15171/jnp.2016.24.10.15171/jnp.2016.24Search in Google Scholar

24. Al-Attar, AM, Alsalmi, FA. Influence of olive leaves extract on hepatorenal injury in streptozotocin diabetic rats. Saudi J Biol Sci 2019; 26: 1865–74. doi:https://doi.org/10.2174/1573399813666170505120621.10.1016/j.sjbs.2017.02.005Search in Google Scholar

25. El Kabbaoui, M, Chda, A, Azdad, O, Mejrhit, N, Aarab, L, Bencheikh, R, et al. Evaluation of hypoglycemic and hypolipidemic activities of aqueous extract of Cistus ladaniferus in streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed 2016; 6: 1044–9. https://doi.org/10.1016/j.apjtb.2016.09.005.10.1016/j.apjtb.2016.09.005Search in Google Scholar

26. Munhoz, A, Frode, TS. Isolated compounds from natural products with potential antidiabetic activity-A systematic review. Curr Diabetes Rev 2018; 14: 36–106.10.2174/1573399813666170505120621Search in Google Scholar

27. Vinayagam, R, Xu, B. Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab 2015; 12: 60. https://doi.org/10.1186/s12986-015-0057-7.10.1186/s12986-015-0057-7Search in Google Scholar

28. Aryaeian, N, Sara, KS, Tahereh, A. Polyphenols and their effects on diabetes management: a review. Med J Islam Repub Iran 2017; 31: 134. https://doi.org/10.14196/mjiri.31.134.10.14196/mjiri.31.134Search in Google Scholar

29. Ghorbani, A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomed Pharmacother 2017; 96: 305–12. https://doi.org/10.1016/j.biopha.2017.10.001.10.1016/j.biopha.2017.10.001Search in Google Scholar

30. Danne, A, Petereit, F, Nahrstedt, A. Flavan-3-ols, prodelphinidins and further polyphenols from Cistus salvifolius. Phytochemistry 1994; 37: 533–8. https://doi.org/10.1016/0031-9422(94)85094-1.10.1016/0031-9422(94)85094-1Search in Google Scholar

31. Gürbüz, P, Demirezer, LÖ, Güvenalp, Z, Kuruüzüm-Uz, A, Kazaz, C. Isolation and structure elucidation of uncommon secondary metabolites from Cistus salviifolius L. Record Nat Prod 2015; 9: 175.Search in Google Scholar

Received: 2020-03-03
Accepted: 2020-06-25
Published Online: 2020-10-05

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 19.4.2024 from https://www.degruyter.com/document/doi/10.1515/jbcpp-2020-0044/html
Scroll to top button